Independence Blue Cross to stop covering Wegovy, Ozempic as weight loss drugs in 2025
Independence Blue Cross said starting Jan. 1 it will only be covering GLP-1 agonists — commonly sold under brand names like ...
dailymemphian17h
‘It’s bonkers’ — how Ozempic, Wegovy change lives of those who struggle to lose weight
Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...
Health on MSN20h
Ozempic May Be Linked to Cause of Sudden Blindness, Another Study Shows
Semaglutide, the active ingredient in Ozempic and Wegovy, has been linked to a condition that can cause permanent vision loss ...
7 types of foods and drinks to avoid when taking Ozempic or Wegovy for weight loss
Weight loss with Ozempic or Wegovy can come with nausea, but avoiding certain foods and drinks can help patients manage the ...
24/7 Wall St2h
Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
WBAL-TV1h
Some patients want to take a holiday pause on weight-loss drugs. Here's what doctors say
The effects that a pause may have on your body may depend on why you're taking the medication in the first place.
FDA approves generic in same class as Ozempic for diabetes. Could it ease shortage, price?
The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...
Yale doctor: Weight loss drugs could also help alcohol cravings
Weight loss drugs like Ozempic and Wegovy have seemingly taken over this year, curbing users appetites by making them feel ...
CT Medicaid accused of violating law by not covering weight loss drugs
One lawmaker said the CT Department of Social Services told him the agency wasn’t paying for FDA-approved drugs because of ...
Will Novo Nordisk (NVO) Stock Recover To $145 Levels?
Novo Nordisk ADR (NYSE: NVO) currently trades at $89 per share, nearly 40% below its peak level of over $145 seen in June of ...
Everyday Health22h
FDA Says Shortages of GLP-1 Drugs Mounjaro and Zepbound Are Over
Tirzepatide, the active ingredient in both Mounjaro for type 2 diabetes and Zepbound for weight loss, was in short supply for ...
Big Take: Weight-Loss Drug Boom’s Prescription Problem
On today’s Big Take podcast, Bloomberg reporter Madison Muller joins host Sarah Holder to share what she’s learned about the ways telehealth can make it easier for people to get prescriptions that ...